<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>In Re: Xarelto (Rivaroxaban) (&#039;310) Patent Litigation :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2021md03017/77416</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2021md03017/77416/feed" rel="self" type="application/rss+xml" />
        <pubDate>Thu, 02 Jul 2026 04:29:52 -0700</pubDate>
        <lastBuildDate>Thu, 02 Jul 2026 04:29:52 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>In Re: Xarelto (Rivaroxaban) (&#039;310) Patent Litigation - Docket Entries - Showing 1 through 169</description>
                                    <item>
        <title>
                            <![CDATA[Document 169]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/27/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978429</guid>
                <pubDate>
            Thu, 27 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 169 in 21md-3017-RGA; D.I. 10 in 23-cv-690-RGA) STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023. Signed by Judge Richard G. Andrews on 7/27/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00690-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978430</guid>
                <pubDate>
            Thu, 27 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 168]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #165 Answer to Complaint, Counterclaim by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978428</guid>
                <pubDate>
            Fri, 21 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 167]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp.. (Hitch, Cortlan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978427</guid>
                <pubDate>
            Fri, 30 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 166]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (Hitch, Cortlan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978426</guid>
                <pubDate>
            Fri, 30 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 165]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Complaint and Counterclaims against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Apotex Inc., Apotex Corp..(Hitch, Cortlan) Modified on 6/30/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978425</guid>
                <pubDate>
            Fri, 30 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 164]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of #157 Letter, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/22/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978424</guid>
                <pubDate>
            Thu, 22 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 163]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 161 in 21-md-3017-RGA; D.I. 22 in 22-cv-1492-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978423</guid>
                <pubDate>
            Wed, 21 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 162]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978421</guid>
                <pubDate>
            Wed, 21 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 10 in 23-cv-327-RGA; D.I. 162 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00327-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978422</guid>
                <pubDate>
            Wed, 21 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 161]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978417</guid>
                <pubDate>
            Tue, 20 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 160]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978416</guid>
                <pubDate>
            Tue, 20 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 159]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 154 in 21-md-3017-RGA; D.I. 17 in 22-cv-1596-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978415</guid>
                <pubDate>
            Tue, 20 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 158]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: The request to file another status report by 6/22/2023 (D.I. 20 in 22-cv-1492-RGA; D.I. 157 in 21-md-3017-RGA) is GRANTED. Ordered by Judge Richard G. Andrews on 6/16/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978414</guid>
                <pubDate>
            Fri, 16 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 157]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 6/16/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978413</guid>
                <pubDate>
            Thu, 15 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 156]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: Defendant USV Private Limited's answer was due to be filed on 6/8/2023 (see D.I. 153 in MDL 21-3017; D.I. 18 in C.A. 22-1492), and to date none has been filed. A status letter is now due no later than three (3) days from the entry of this Order. Ordered by Judge Richard G. Andrews on 6/12/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978412</guid>
                <pubDate>
            Mon, 12 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 155]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978411</guid>
                <pubDate>
            Fri, 02 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 154]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978410</guid>
                <pubDate>
            Fri, 02 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #153 Unopposed Motion to Extend Time (*Reset Answer Deadlines: USV Private Limited answer due 6/8/2023). Signed by Judge Richard G. Andrews on 6/1/2023. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978409</guid>
                <pubDate>
            Thu, 01 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 153]]>
                    </title>
                <description>
            <![CDATA[
                Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/1/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978408</guid>
                <pubDate>
            Wed, 31 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 152]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 151 in 21-md-3017-RGA; D.I. 11 in 23-cv-335-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 5/3/2023. Associated Cases: 1:23-cv-00335-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978407</guid>
                <pubDate>
            Wed, 03 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 151]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION of Dismissal, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/3/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978406</guid>
                <pubDate>
            Wed, 03 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 150]]>
                    </title>
                <description>
            <![CDATA[
                Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/27/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978404</guid>
                <pubDate>
            Thu, 27 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #150 Unopposed Motion to Extend Time to file answer or otherwise respond to June 1, 2023. Signed by Judge Richard G. Andrews on 4/27/2023. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978405</guid>
                <pubDate>
            Thu, 27 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 149]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Patricia Smink Rogowski on behalf of ScieGen Pharmaceuticals, Inc. (Rogowski, Patricia) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978403</guid>
                <pubDate>
            Wed, 12 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 148]]>
                    </title>
                <description>
            <![CDATA[
                UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until to May 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 3/24/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978401</guid>
                <pubDate>
            Fri, 24 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 148 in 21-md-3017-RGA; D.I. 16 in 22-cv-1492-RGA) Unopposed Motion to Extend Time to Answer or otherwise respond to the Complaint to May 1, 2023. Signed by Judge Richard G. Andrews on 3/24/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978402</guid>
                <pubDate>
            Fri, 24 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 147]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Appearance of Delaware Counsel, Eve Ormerod by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978400</guid>
                <pubDate>
            Fri, 17 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 146]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Apotex's ANDA Production and (2) Apotex's Core Technical Documents Production filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978399</guid>
                <pubDate>
            Wed, 08 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 145]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978397</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 144]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978396</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 143]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978395</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 142]]>
                    </title>
                <description>
            <![CDATA[
                Answer to Complaint, Separate Defenses and Counterclaims, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 3/7/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978394</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 14 in 22-cv-1596-RGA; D.I. 145 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 3/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978398</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 141]]>
                    </title>
                <description>
            <![CDATA[
                UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/28/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978392</guid>
                <pubDate>
            Tue, 28 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re ( D.I. 15 in 22-cv-1492-RGA; D.I. 141 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023. Signed by Judge Richard G. Andrews on 2/28/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21978393</guid>
                <pubDate>
            Tue, 28 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 140]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Viatris Inc. for Mylan Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863417</guid>
                <pubDate>
            Wed, 01 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 139]]>
                    </title>
                <description>
            <![CDATA[
                Unopposed Motion for Extension of Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/31/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863415</guid>
                <pubDate>
            Tue, 31 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 139 in 21-md-3017-RGA; D.I. 14 in 22-cv-1492-RGA) Unopposed Motion for Extension of Time to answer or otherwise respond to the Complaint until 2/28/2023. Signed by Judge Richard G. Andrews on 1/31/2023. Associated Cases: 1:22-cv-01492-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863416</guid>
                <pubDate>
            Tue, 31 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 138]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: For the reasons stated on the record on January 18, 2023, a stay of the case is GRANTED until fourteen days after the PTAB issues a final written decision on the related IPR. At that time, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. The motion to extend schedule (D.I. 125) is DISMISSED as moot. Ordered by Judge Richard G. Andrews on 1/18/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863413</guid>
                <pubDate>
            Wed, 18 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing on the Motion to Extend Schedule held on 1/18/2023. Counsel for Plaintiffs: D. Fahnestock. Counsel for Defendants: N. Hoeschen, M. Haney, N. Belgam, R. Vrana, D. Moore. No later than 14 days after the PTAB decision, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. (Court Reporter Heather Triozzi.) Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(lah) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863414</guid>
                <pubDate>
            Wed, 18 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 137]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: A hearing on the Motion to Extend Schedule (D.I. 134 in 21-cv-314-RGA-JLH; D.I. 113 in 21-cv-1742-RGA; D.I. 125 in 21-md-3017-RGA) is now set for 1/18/2023, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/6/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863412</guid>
                <pubDate>
            Fri, 06 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, Granting (D.I. 12 in 22-cv-1492-RGA; D.I. 136 in 21-md-3017-RGA) Unopposed Motion to Extend Time to answer or otherwise respond to Complaint to January 31, 2023. Signed by Judge Richard G. Andrews on 1/5/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863411</guid>
                <pubDate>
            Thu, 05 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 136]]>
                    </title>
                <description>
            <![CDATA[
                UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/5/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863410</guid>
                <pubDate>
            Wed, 04 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 135]]>
                    </title>
                <description>
            <![CDATA[
                Letter to The Honorable Richard G. Andrews, from Emily S. DiBenedetto, regarding request for oral argument. (DiBenedetto, Emily) Modified on 1/4/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863409</guid>
                <pubDate>
            Tue, 03 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 134]]>
                    </title>
                <description>
            <![CDATA[
                REPLY Brief in further support to #125 MOTION to Extend Case Schedule, filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit A)(Hoeschen, Nathan) Modified on 12/28/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863408</guid>
                <pubDate>
            Tue, 27 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 133]]>
                    </title>
                <description>
            <![CDATA[
                ANSWERING BRIEF in Opposition re #125 MOTION to Extend Schedule, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/27/2022. (Fahnestock, Derek) Modified on 12/16/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863407</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 132]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by James S. Green, Jr on behalf of USV Private Limited (Green, James) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863406</guid>
                <pubDate>
            Wed, 14 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 131]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Motion to Extend Schedule (D.I. #125 ), by Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s. (Ormerod, Eve) Modified on 12/14/2022 (nms). Modified on 12/15/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863405</guid>
                <pubDate>
            Wed, 14 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 130]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Proposed Order to Extend Time to file their response to Defendants' Motion to Extend Schedule - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/13/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863402</guid>
                <pubDate>
            Tue, 13 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 129]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order to Extend Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863401</guid>
                <pubDate>
            Tue, 13 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 137 in 21-cv-314-RGA-JLH; D.I. 116 in 21-cv-1742-RGA, D.I. 129 in 21-md-03017-RGA) Stipulation and Proposed Order to Extend Schedule. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863404</guid>
                <pubDate>
            Tue, 13 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 130 in 21-md-3017-RGA; D.I. 138 in 21-cv-314-RGA-JLH; D.I. 117 in 21-cv-01742-RGA) STIPULATION and Proposed order to Extend Time to file response to Defendants' Motion to Extend Schedule to December 16, 2022. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863403</guid>
                <pubDate>
            Tue, 13 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 128]]>
                    </title>
                <description>
            <![CDATA[
                UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/5/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863399</guid>
                <pubDate>
            Mon, 05 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 10 in 22-cv-1492-RGA; D.I. 128 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer the complaint to 1/5/2023. Signed by Judge Richard G. Andrews on 12/5/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863400</guid>
                <pubDate>
            Mon, 05 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 127]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiff Bayer's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) and (2) Plaintiff Janssen's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863398</guid>
                <pubDate>
            Fri, 02 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 126]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863396</guid>
                <pubDate>
            Thu, 01 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 126 in 21-md-3017-RGA; D.I. 114 in 21-cv-1742-RGA; D.I. 135 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/1/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863397</guid>
                <pubDate>
            Thu, 01 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Set Answering Brief Deadline re #125 MOTION to Extend Schedule. Answering Brief/Response due date per Local Rules is 12/13/2022. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863395</guid>
                <pubDate>
            Tue, 29 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 125]]>
                    </title>
                <description>
            <![CDATA[
                MOTION to Extend Schedule - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 11/29/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863394</guid>
                <pubDate>
            Tue, 29 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                CORRECTING ENTRY: The motion to extend schedule filed on 11/28/2022, has been removed from the docket. The filer requested this as an amended motion will be refiled. Associated Cases: 1:21-cv-01742-RGA, 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863393</guid>
                <pubDate>
            Tue, 29 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 124]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 123 in 21-md-3017-RGA; D.I.132 in 21-cv-314-RGA-JLH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/16/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863392</guid>
                <pubDate>
            Wed, 16 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 123]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Order regarding Infringement by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863391</guid>
                <pubDate>
            Wed, 16 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 122]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE requesting Clerk to remove David M. Knapp as co-counsel.. (Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863390</guid>
                <pubDate>
            Mon, 14 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 121]]>
                    </title>
                <description>
            <![CDATA[
                CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (35 in MDL No. 3017, 2 in NJ/2:22-cv-05485) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 11/14/2022. (Attachments: #1 Transferee Letter) (smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863389</guid>
                <pubDate>
            Mon, 14 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 120]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Change of Firm Affiliation by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863388</guid>
                <pubDate>
            Fri, 11 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 119]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Mylan Pharmaceutical Inc. and Mylan Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863387</guid>
                <pubDate>
            Mon, 07 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 118]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Janssen Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863386</guid>
                <pubDate>
            Wed, 02 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 117]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Bayer Pharma AG and Bayer AG filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863385</guid>
                <pubDate>
            Wed, 02 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 116]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Frank Misselwitz filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863384</guid>
                <pubDate>
            Wed, 02 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 115]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Nancy Cook Bruns filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863383</guid>
                <pubDate>
            Wed, 02 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 114]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863382</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 113]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 123 in 21-cv-314-RGA-JLH; D.I. 112 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/19/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863381</guid>
                <pubDate>
            Wed, 19 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 112]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Order Regarding Infringement (as to Defendants Lupin Limited and Lupin Pharmaceutical, Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863380</guid>
                <pubDate>
            Tue, 18 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 111]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s Identification References & Combinations filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Belgam, Neal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863379</guid>
                <pubDate>
            Tue, 18 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 110]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 107 in 21-md-3017-RGA; D.I. 39 in 22-cv-1228-RGA; D.I. 104 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order Consolidating Cases and Adopting Schedule. Signed by Judge Richard G. Andrews on 10/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA, 1:22-cv-01228-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863378</guid>
                <pubDate>
            Tue, 18 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 109]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863377</guid>
                <pubDate>
            Tue, 18 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 108]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Prior Art Narrowing Disclosure (also filed on behalf of Defendant Teva Pharmaceuticals USA, Inc.) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863376</guid>
                <pubDate>
            Mon, 17 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 107]]>
                    </title>
                <description>
            <![CDATA[
                Joint Stipulation and [Proposed] Order Consolidating Cases and Adopting Schedule, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/18/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863375</guid>
                <pubDate>
            Mon, 17 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 106]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Defendants' Motion to Dismiss by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/17/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863374</guid>
                <pubDate>
            Mon, 17 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 105]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of #99 Answering Brief in Opposition, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Fahnestock, Derek) Modified on 10/12/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863373</guid>
                <pubDate>
            Wed, 12 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 104]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 117 in 21-cv-314-RGA-JLH; D.I. 102 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863372</guid>
                <pubDate>
            Wed, 12 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 103]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 116 in 21-cv-314-RGA-JLH; D.I. 101 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/11/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863371</guid>
                <pubDate>
            Tue, 11 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 102]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863370</guid>
                <pubDate>
            Tue, 11 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 101]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/11/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863369</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 100]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Fahnestock, Derek) Modified on 10/3/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863368</guid>
                <pubDate>
            Mon, 03 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 99]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] ANSWERING BRIEF in Opposition re Motion to Dismiss (D.I. 25 in C.A. 22-1228-RGA), filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 10/11/2022. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Fahnestock, Derek) Modified on 10/3/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863367</guid>
                <pubDate>
            Mon, 03 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 98]]>
                    </title>
                <description>
            <![CDATA[
                Joint Stipulation and [Proposed] Order to Extend Time, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 9/30/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863365</guid>
                <pubDate>
            Fri, 30 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 98 in 21-md-3017-RGA; D.I. 115 in 21-cv-314-RGA-JLH; D.I. 103 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 9/30/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863366</guid>
                <pubDate>
            Fri, 30 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 97]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME (1) for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to respond to Defendants' Motion to Dismiss (D.I. 25); and (2) for Defendants to file their reply brief to October 3, 2022, and October 17, 2022, respectively - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863363</guid>
                <pubDate>
            Fri, 23 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 97 in 21-md-3017-RGA; D.I. 34 in 22-cv-1228-RGA) STIPULATION and Proposed Order to Extend Time to respond to Motion to Dismiss and to file reply brief to October 3, 2022, and October 17, 2022. Signed by Judge Richard G. Andrews on 9/23/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01228-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863364</guid>
                <pubDate>
            Fri, 23 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 96]]>
                    </title>
                <description>
            <![CDATA[
                CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. (29 in MDL No. 3017, 1 in WVN/1:22-cv-00063) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/21/2022. (Attachments: #1 Transferee Letter) (smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863362</guid>
                <pubDate>
            Wed, 21 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 95]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Wayne Talton on October 14, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863361</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 94]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Kristen McElwayne on October 13, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863360</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 93]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Beth Britton on October 6, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863359</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 92]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Natalie Yantovskiy on October 19, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863358</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 91]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Miriam Getsis on October 12, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863357</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 90]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Avi Avramoff on October 5, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863356</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 89]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Makrand Avichat on October 18, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863355</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 88]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Pramod Dahibhate on October 11, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863354</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 87]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Jason Gensburger on October 4, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863353</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 86]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Srinivasa Rao on October 17, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863352</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 85]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Sowjanya Madala on October 10, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863351</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 84]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Shobha Chagam on October 3, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863350</guid>
                <pubDate>
            Mon, 19 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 83]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.; (2) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.; (3) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.; and (4) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendant Teva Pharmaceuticals USA, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863349</guid>
                <pubDate>
            Mon, 12 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 82]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863348</guid>
                <pubDate>
            Mon, 12 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 81]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863346</guid>
                <pubDate>
            Fri, 09 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 80]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s First Supplemental Objections and Responses to Plaintiffs Bayer Pharma AG and Janssen Pharmaceuticals, Inc.s First Joint Set of Interrogatories filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863345</guid>
                <pubDate>
            Fri, 09 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 81 in 21-md-3017-RGA; D.I. 98 in 21-cv-1742-RGA; D.I. 104 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers, filed by Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 9/9/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863347</guid>
                <pubDate>
            Fri, 09 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 79]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863343</guid>
                <pubDate>
            Thu, 08 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 78]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863341</guid>
                <pubDate>
            Thu, 08 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 102 in 21-cv-314-RGA-JLH; D.I. 97 in 21-cv-1742-RGA; D.I. 79 in 21-md-3017-RGA) STIPULATION to Extend Time to substantially complete document production to September 23, 2022. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863344</guid>
                <pubDate>
            Thu, 08 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 78 in 21-md-3017-RGA; D.I. 101 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863342</guid>
                <pubDate>
            Thu, 08 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 77]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863340</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 76]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863339</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 75]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863338</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 74]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863337</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 73]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. and Mylan Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863336</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 72]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Change of Address by Megan C. Haney (Haney, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863335</guid>
                <pubDate>
            Tue, 30 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 71]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 94 in 21-cv-1742-RGA; D.I. 70 in 21-md-3017-RGA; 94 in 21-cv-314-RGA-JLH) STIPULATION to Extend Time for Plaintiffs and Defendants to substantially complete document production to September 9, 2022. Signed by Judge Richard G. Andrews on 8/24/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863334</guid>
                <pubDate>
            Wed, 24 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 70]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 9, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863333</guid>
                <pubDate>
            Wed, 24 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 69]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) and (2) Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863332</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863331</guid>
                <pubDate>
            Wed, 27 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 68]]>
                    </title>
                <description>
            <![CDATA[
                Joint STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production shall be extended from August 5, 2022 to allow the parties additional time to search for and produce documents to August 26, 2022 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863330</guid>
                <pubDate>
            Tue, 26 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 67]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 66 in 21-md-3017-RGA; D.I. 90 in 21-cv-314-RGA-JLH) Stipulation of Dismissal (*Micro Labs USA, Inc. and Micro Labs Limited terminated). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863329</guid>
                <pubDate>
            Tue, 12 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 66]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/7/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863328</guid>
                <pubDate>
            Wed, 06 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 65]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Lupin's First Set of Requests for Production to Plaintiffs (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863327</guid>
                <pubDate>
            Wed, 06 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 64]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Hitch, Cortlan) Modified on 7/1/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863325</guid>
                <pubDate>
            Fri, 01 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 88 in 21-cv-314-RGA-JLH; D.I. 64 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order (between Plaintiffs and Defendants "Micro"). Signed by Judge Richard G. Andrews on 7/1/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863326</guid>
                <pubDate>
            Fri, 01 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 63]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 62 in 21-md-3017-RGA: D.I. 86 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/27/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863324</guid>
                <pubDate>
            Mon, 27 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 62]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION Amend Scheduling Order as to Plaintiffs and Micro Labs by Micro Labs Ltd.. (Hitch, Cortlan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863323</guid>
                <pubDate>
            Fri, 24 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 61]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863321</guid>
                <pubDate>
            Fri, 10 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 61 in 21-md-3017-RGA; D.I. 85 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 6/10/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863322</guid>
                <pubDate>
            Fri, 10 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 60]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863320</guid>
                <pubDate>
            Thu, 09 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 59]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s 1) Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) and 2) Responses and Objections to Plaintiffs' First Joint Set of Interrogatories (Nos. 1-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863319</guid>
                <pubDate>
            Wed, 08 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 58]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Joint Set of Interrogatories; and 2) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Set of Requests for Production filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863318</guid>
                <pubDate>
            Tue, 07 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 57]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Joint Set Of Interrogatories (Nos. 1-7), and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Set Of Requests For Production (Nos. 1-43) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863317</guid>
                <pubDate>
            Tue, 07 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 56]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories 2. Teva's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1 - 43) filed by Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863316</guid>
                <pubDate>
            Tue, 07 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 55]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and Lupin's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863315</guid>
                <pubDate>
            Mon, 06 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 54]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 77 in 21-cv-314-RGA-JLH; D.I. 53 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/2/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863314</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 53]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amended Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863313</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 52]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863312</guid>
                <pubDate>
            Wed, 01 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Frank D. Rodriguez for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863311</guid>
                <pubDate>
            Wed, 01 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 51]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863309</guid>
                <pubDate>
            Tue, 31 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 51 in 21-md-3017-RGA; D.I. 75 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 5/31/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863310</guid>
                <pubDate>
            Tue, 31 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney David M. Knapp for Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863308</guid>
                <pubDate>
            Wed, 25 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 74 in 21-cv-314-RGA-JLH; D.I. 50 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 5/25/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863307</guid>
                <pubDate>
            Wed, 25 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 50]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863306</guid>
                <pubDate>
            Tue, 24 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 49]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863305</guid>
                <pubDate>
            Tue, 24 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 48]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863304</guid>
                <pubDate>
            Tue, 24 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863303</guid>
                <pubDate>
            Tue, 24 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 47]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863302</guid>
                <pubDate>
            Mon, 23 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 46]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amend the Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863300</guid>
                <pubDate>
            Mon, 23 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 46 in 21-md-3017-RGA; D.I. 70 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/23/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863301</guid>
                <pubDate>
            Mon, 23 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863299</guid>
                <pubDate>
            Fri, 20 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 45]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863298</guid>
                <pubDate>
            Thu, 19 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 44]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED Granting (D.I. 84 in 21-cv-1742-RGA; D.I. 42 in 21-md-3017-RGA) Stipulation Amending Order. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863297</guid>
                <pubDate>
            Wed, 18 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863296</guid>
                <pubDate>
            Wed, 18 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 43]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863295</guid>
                <pubDate>
            Tue, 17 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 42]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION Amending Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863294</guid>
                <pubDate>
            Tue, 17 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 41]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863292</guid>
                <pubDate>
            Fri, 13 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 40]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME various dates to dates listed in stipulation - filed by Micro Labs Ltd., Micro Labs USA Inc., Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863290</guid>
                <pubDate>
            Fri, 13 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863293</guid>
                <pubDate>
            Fri, 13 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 66 in 21-cv-314-RGA-JLH; D.I. 40 in 21-md-3017-RGA) STIPULATION to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863291</guid>
                <pubDate>
            Fri, 13 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 39]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Constructions filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863289</guid>
                <pubDate>
            Mon, 02 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 38]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863288</guid>
                <pubDate>
            Mon, 02 May 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #36 Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/29/2022. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863287</guid>
                <pubDate>
            Fri, 29 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 37]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863286</guid>
                <pubDate>
            Fri, 29 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 36]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amended Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) Modified on 4/29/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863285</guid>
                <pubDate>
            Fri, 29 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 35]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863284</guid>
                <pubDate>
            Fri, 22 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 34]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' First Set Of Joint Interrogatories To Plaintiffs (Nos. 1-9); and Defendants' First Set Of Joint Requests For Production To Plaintiffs (Nos. 1-60) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863283</guid>
                <pubDate>
            Mon, 18 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 33]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs) by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863281</guid>
                <pubDate>
            Mon, 18 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 59 in 21-cv-314-RGA-JLH; D.I. 33 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863282</guid>
                <pubDate>
            Mon, 18 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 32]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863280</guid>
                <pubDate>
            Fri, 15 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 31]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Micro Labs' Rule 26(a)(1) Initial Disclosures; and (2) Micro Labs' Paragraph 3 Disclosures filed by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863279</guid>
                <pubDate>
            Tue, 05 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 30]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures, (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures, and (3) Bayer Pharma AG, Bayer AG's, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863278</guid>
                <pubDate>
            Fri, 01 Apr 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 29]]>
                    </title>
                <description>
            <![CDATA[
                Answer to Counterclaims of Defendants Micro Labs Ltd. and Micro Labs USA, Inc. (see C.A. 22-165-RGA, D.I. 10), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/28/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863277</guid>
                <pubDate>
            Mon, 28 Mar 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 28]]>
                    </title>
                <description>
            <![CDATA[
                SCHEDULING ORDER: Civil Action No. 22-165-RGA is consolidated for all purposes, including trial, with Civil Action 21-314-RGA, and all papers shall be filed in Civil Action No. 21-314-RGA. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 7/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A 2 day Bench Trial is set to start 5/30/2023, at 8:30 AM in Courtroom 6A. Signed by Judge Richard G. Andrews on 3/22/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-00165-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863276</guid>
                <pubDate>
            Tue, 22 Mar 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 27]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: #1 Letter)(Fahnestock, Derek) Modified on 3/21/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863275</guid>
                <pubDate>
            Mon, 21 Mar 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 26]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Micro Labs Ltd. for Micro Labs USA, Inc. filed by Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863274</guid>
                <pubDate>
            Tue, 08 Mar 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 25]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Complaint and COUNTERCLAIM against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) Modified on 3/9/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863273</guid>
                <pubDate>
            Tue, 08 Mar 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 24]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863272</guid>
                <pubDate>
            Wed, 02 Mar 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 23]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Moore, David) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863271</guid>
                <pubDate>
            Wed, 02 Mar 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 22]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions with Ex. A filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19863270</guid>
                <pubDate>
            Tue, 01 Mar 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 21]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126006</guid>
                <pubDate>
            Mon, 31 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 20]]>
                    </title>
                <description>
            <![CDATA[
                ORDER ADOPTING SCHEDULE: The 314 Scheduling Order shall govern in this Action as if entered in this action, except that paragraphs 14-16 pertaining to the pretrial and trial shall not be applicable. Signed by Judge Richard G. Andrews on 1/31/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126005</guid>
                <pubDate>
            Mon, 31 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 19]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED Order Adopting Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Attachments: #1 Letter)(Fahnestock, Derek) Modified on 1/31/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126004</guid>
                <pubDate>
            Mon, 31 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 18]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Teva's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126003</guid>
                <pubDate>
            Fri, 28 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 17]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Taro's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126002</guid>
                <pubDate>
            Fri, 28 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 16]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Mylan's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126001</guid>
                <pubDate>
            Fri, 28 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 15]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Lupin's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15126000</guid>
                <pubDate>
            Fri, 28 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for DRL's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125999</guid>
                <pubDate>
            Fri, 28 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: The parties are requested to jointly submit a proposed order formally adopting the schedule already in place for related consolidated civil action 21-314-RGA. The proposed order is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/25/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125998</guid>
                <pubDate>
            Tue, 25 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                Joint Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 1/18/2022 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125997</guid>
                <pubDate>
            Tue, 18 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: A joint status letter is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125996</guid>
                <pubDate>
            Wed, 12 Jan 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Disclosures Pursuant To Paragraph 3 Of The Delaware Default Standard Of Discovery; and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Production Of Core Technical Documents Pursuant To Paragraph 4(b) Of Delawares Default Standard For Discovery [CONFIDENTIAL] filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Moore, David) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125995</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125994</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125993</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Default Standard Paragraph 3 and 4(b) Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125992</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125991</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorneys Wendy L. Devine, Elham F. Steiner, and Ty W. Callahan for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125990</guid>
                <pubDate>
            Wed, 29 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125988</guid>
                <pubDate>
            Tue, 28 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (D.I. 5 in 21-md-3017-RGA,; D.I. 69 in 21-cv-1742-RGA) MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/28/2021. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125989</guid>
                <pubDate>
            Tue, 28 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1) Initial Disclosures of Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc. Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc.'s core technical documents filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_15125987</guid>
                <pubDate>
            Mon, 27 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Answer to Complaint and Counterclaim, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/20/2021 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607812</guid>
                <pubDate>
            Fri, 17 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Dismissal Without Prejudice of Taro's Counterclaims as to U.S. Patent 9,415,053 by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607811</guid>
                <pubDate>
            Thu, 16 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607807</guid>
                <pubDate>
            Wed, 15 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Remark: The following cases in the District of Delaware are included in this MDL: 21-cv-314, 21-cv-732, 21-cv-1000, 21-cv-1001, 21-cv-1742. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607810</guid>
                <pubDate>
            Wed, 15 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607809</guid>
                <pubDate>
            Wed, 15 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_14607808</guid>
                <pubDate>
            Wed, 15 Dec 2021 00:00:00 -0800
        </pubDate>
    </item>
                </channel>
</rss>
